HIV-1 AND HIV-2 DUAL INFECTION - LACK OF HIV-2 PROVIRUS CORRELATES WITH LOW CD4+ LYMPHOCYTE COUNTS

Citation
Ad. Sarr et al., HIV-1 AND HIV-2 DUAL INFECTION - LACK OF HIV-2 PROVIRUS CORRELATES WITH LOW CD4+ LYMPHOCYTE COUNTS, AIDS, 12(2), 1998, pp. 131-137
Citations number
31
Categorie Soggetti
Immunology,"Infectious Diseases",Virology
Journal title
AIDSACNP
ISSN journal
02699370
Volume
12
Issue
2
Year of publication
1998
Pages
131 - 137
Database
ISI
SICI code
0269-9370(1998)12:2<131:HAHDI->2.0.ZU;2-0
Abstract
Objective: We conducted this study to genetically characterize dual in fection in individuals demonstrating a dual serological profile. Metho ds: All subjects were first evaluated by immunoblot for antibody react ivity to the major viral antigens for HIV-1 and HIV-2. Sera were judge d to be dual-seropositive if they reacted with strong and equal intens ity with the envelope antigens of both HIV-1 and HIV-2 and were confir med with type-specific recombinant env peptides. We used nested polyme rase chain reaction (PCR) to proviral gag and env sequence from periph eral blood mononuclear cell amplify (PBMC) DNA from HIV-1- and HIV-2-i nfected individuals. Positive amplification was detected after Souther n blot hybridization. Results: Plasmid dilution and mixing showed equi valent sensitivity of HIV-1 and HIV-2 primers that was not altered by heterologous target sequences. The DNA PCR showed 100% sensitivity and specificity for detection of monotypic HIV infection. Serologically d efined HIV-dual reactives were evaluated by this assay, with 100% dete ction in female sex workers (21 out of 21), but only 38.5% detection ( five out of 13) in hospitalized patients; all being HIV-1 positive onl y. The lack of HIV-2 proviral signal was significantly correlated with low CD4+ lymphocyte counts (P value = 0.04). Conclusion: The results suggest that HIV dual infection may not be a static condition. Levels of HIV-2 may decrease with disease progression or sequester in tissue reservoirs; our results may also suggest that HIV-1 effectively overgr ows HIV-2 in the dually exposed host individual.